Consequence of the tumor‐associated conversion to cyclin D1b
Abstract Clinical evidence suggests that cyclin D1b, a variant of cyclin D1, is associated with tumor progression and poor outcome. However, the underlying molecular basis was unknown. Here, novel models were created to generate a genetic switch from cyclin D1 to cyclin D1b. Extensive analyses uncov...
Saved in:
| Main Authors: | Michael A Augello, Lisa D Berman‐Booty, Richard Carr, Akihiro Yoshida, Jeffry L Dean, Matthew J Schiewer, Felix Y Feng, Scott A Tomlins, Erhe Gao, Walter J Koch, Jeffrey L Benovic, John Alan Diehl, Karen E Knudsen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2015-03-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201404242 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclin F Expression in Clear Cell Renal Cell Carcinoma and Its Effect on Biological Behavior of Renal Carcinoma Cell Lines
by: Min SU, et al.
Published: (2025-06-01) -
Research progress on cell cycle regulation-related molecules in the development of oral squamous cell carcinoma
by: HOU Zeyu, et al.
Published: (2023-04-01) -
Towards the Rational Design of Monovalent Degraders: Lessons Learnt from Cyclin K Degraders
by: Katie L. Thomas, et al.
Published: (2025-03-01) -
Feelin’ it: Differential oxidative stress sensing mediated by Cyclin C
by: W. Scott Moye-Rowley
Published: (2015-09-01) -
Prognostic Value of Cyclin D1 Overexpression in Invasive Breast Carcinoma
by: Funda Taşlı, et al.
Published: (2025-04-01)